We are live on
!
Find out more
MCM
Mengis Capital Management Portfolio holdings
AUM
$581M
1-Year Est. Return
28.04%
This Fund
S&P 500
This Quarter
Est. Return
+7.25%
1 Year Est. Return
+28.04%
3 Year Est. Return
+72.9%
5 Year Est. Return
+105.39%
10 Year Est. Return
+334.2%
AUM
$501M
AUM Growth
+$26.6M
(+5.6%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
171
New
6
Increased
40
Reduced
77
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$1.14M |
| 2 |
Freeport-McMoran
FCX
|
+$672K |
| 3 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$620K |
| 4 |
Agilent Technologies
A
|
+$620K |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$549K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$3.2M |
| 2 |
US Bancorp
USB
|
+$925K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$588K |
| 4 |
Merck
MRK
|
+$557K |
| 5 |
Microsoft
MSFT
|
+$484K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.86% |
| 2 | Industrials | 19.89% |
| 3 | Healthcare | 15.97% |
| 4 | Consumer Staples | 9.06% |
| 5 | Energy | 6.65% |
Similar funds
TCM
JCP
AF
TCMX
DLCIG
GF
IIA
BL
Mengis Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Mengis Capital Management held 171 positions worth $501M, up 5.6% from $475M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Mengis Capital Management's Q2 2023 filing shows 6 new, 40 increased, 77 reduced and 5 closed positions. Its largest new stake was Freeport-McMoran: 17,645 shares worth $706K. The largest sale was Vanguard Ultra-Short Bond ETF, an estimated $3.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
- Mengis Capital Management's largest Q2 2023 buy was Freeport-McMoran: 17,645 shares worth $706K.
- Mengis Capital Management added most to PNC Financial Services in Q2 2023, an estimated $1.14M increase.
- Mengis Capital Management's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $588K.
- Mengis Capital Management fully exited Vanguard Ultra-Short Bond ETF in Q2 2023, selling an estimated $3.2M.
- Mengis Capital Management's ten largest holdings make up 41% of its $501M portfolio in Q2 2023.
- Mengis Capital Management opened 6 new positions and closed 5 in Q2 2023.
- Mengis Capital Management's portfolio value rose 5.6% quarter-over-quarter to $501M.
Based on Mengis Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.